Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Safety, Pharmacokinetics and Pharmacodynamics of MEDI6012 in Subjects With Stable Coronary Artery Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00715078).
- To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate Sperm Parameters in Men With Secondary Hypogonadism Previously Treated With Topical Testosterone: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Effect of Moisturizing Creams on Skin Barrier Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Evaluate the Efficacy of Eleutherococcus Senticosus for Subjects Under Renal Dialysis: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Efficacy of Eleutherococcus Senticosus for Subjects Under Renal Dialysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET): Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET): primary endpoint results, effect estimate with…
- To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Safety and Efficacy of the Saline-coupled Bipolar Sealer in Primary Unilateral Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Safety, Tolerability, and Efficacy of TMC207 as Part of an Individualized Multi-drug Resistant Tuberculosis (MDR-TB) Treatment Regimen in Participants With Sputum Smear-positive Pulmonary MDR-TB.: primary…
- To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older: Complete Statistical AnalysisIndependent statistical analysis of To Evaluate the Safety, Tolerability, and Immunogenicity of BNT162b2 Against COVID-19 in Healthy Pregnant Women 18 Years of Age and Older: primary endpoint results, effect estimate with confidence…
- To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: Complete Statistical AnalysisIndependent statistical analysis of To Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 1467335 Following Multiple Dose Administration Over 28 Days: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler…
- To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH): Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Efficacy of an Occluding Dentifrice in Dentinal Hypersensitivity (DH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: Complete Statistical AnalysisIndependent statistical analysis of To Investigate the Relative Efficacy of Terbutaline Turbuhaler® and Salbutamol Pressurized Metered Dose Inhaler (pMDI) a Single Blind Study: primary endpoint results, effect estimate with confidence interval, sample-size…
- To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting: Complete Statistical AnalysisIndependent statistical analysis of To Measure Pain Perception Following De-Epithelized Free Gingival Graft Harvesting: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03895476).
- To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research: Complete Statistical AnalysisIndependent statistical analysis of To Measure Pain Perception With Electronic Pressure Algometer of Different Size Probes : a Healthy Subjects Research: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks: Complete Statistical AnalysisIndependent statistical analysis of To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: Complete Statistical AnalysisIndependent statistical analysis of To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.: Complete Statistical AnalysisIndependent statistical analysis of To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.: Complete Statistical AnalysisIndependent statistical analysis of To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects: Complete Statistical AnalysisIndependent statistical analysis of To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- TOBA II BTKIndependent statistical analysis of Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tobacco Cessation at FDNY: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Cessation at FDNY: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05997225).
- Tobacco Use Treatment in Cancer Patients: Complete Statistical AnalysisIndependent statistical analysis of Tobacco Use Treatment in Cancer Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03482583).
- TOBEIndependent statistical analysis of The Digital Breast Tomosynthesis Trial in Bergen: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02835625).
- TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: Complete Statistical AnalysisIndependent statistical analysis of TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- TOCIndependent statistical analysis of A Transition of Care Model From Hospital to Community for Hispanic/Latino Adult Patients With Diabetes.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- TOCCATAIndependent statistical analysis of TOCCATA - Touch+™ for Catheter Ablation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01223469).
- Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab as Add-On Treatment For Residual Positive, Negative, and Cognitive Symptoms of Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Tocilizumab for Patients With Giant Cell Arteritis: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for Patients With Giant Cell Arteritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01450137).
- Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Tocilizumab for the Treatment of Behcet’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Tocilizumab for the Treatment of Behcet's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693653).
- TOCPIndependent statistical analysis of Tailoring Online Continence Promotion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05183217).
- TODIndependent statistical analysis of Together Overcoming Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04734015).
- Tofacitinib for the Treatment of Alopecia Areata and Its Variants: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib for the Treatment of Alopecia Areata and Its Variants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02312882).
- Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib Hypothesis-generating, Pilot Study for Corticosteroid-Dependent Sarcoidosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03793439).
- Tofacitinib Ointment For Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of Tofacitinib Ointment For Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01831466).
- TOFUIndependent statistical analysis of A Phase II Study of RBM-007 Alone and RBM-007 With Eylea® in Subjects With Wet Age-related Macular Degeneration: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- TOGETHERIndependent statistical analysis of Prevalence and Incidence of Articular Symptoms and Signs Related to Psoriatic Arthritis in Patients With Psoriasis Severe or Moderate With Adalimumab Treatment: primary endpoint results, effect estimate with…
- Tolcapone in Obsessive Compulsive Disorder: Complete Statistical AnalysisIndependent statistical analysis of Tolcapone in Obsessive Compulsive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03348930).
- Tolcapone Treatment of Pathological Gambling: Complete Statistical AnalysisIndependent statistical analysis of Tolcapone Treatment of Pathological Gambling: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00927563).
- Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age: Complete Statistical AnalysisIndependent statistical analysis of Tolerability , PK/PD and Safety of Dabigatran Etexilate Oral Liquid Formulation in Children < 1 Year of Age: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study): Complete Statistical AnalysisIndependent statistical analysis of Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study): primary endpoint results,…
- Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: Complete Statistical AnalysisIndependent statistical analysis of Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.: Complete Statistical AnalysisIndependent statistical analysis of Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: Complete Statistical AnalysisIndependent statistical analysis of Tolerability of Bimatoprost 0.01% vs Latanoprost Eye Drops: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02138461).
- Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis: Complete Statistical AnalysisIndependent statistical analysis of Tolerability of Hypertonic Saline in Infants With Cystic Fibrosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00753987).